Status:
RECRUITING
Incidence and Characterization of Drivers Oncogenes in the Population With Lung Cancer Afferents to the Cancer Institute in Aviano (IN.ON.D.)
Lead Sponsor:
Centro di Riferimento Oncologico - Aviano
Conditions:
Non Small Cell Lung Cancer
Eligibility:
All Genders
Brief Summary
According to an analysis by Memorial Sloan Kettering Cancer Center patients who receive a target therapy having an oncogenic driver mutation live longer than those who do not receive it. In addition t...
Detailed Description
According to an analysis by Memorial Sloan Kettering Cancer Center patients who receive a target therapy having an oncogenic driver mutation live longer than those who do not receive it. In addition t...
Eligibility Criteria
Inclusion
- First visit or first admission to CRO occurred in the period from September 2023 to September 2028
- Diagnosis of NSCLC any stage
Exclusion
- \- Diagnosis of tumor not of certain lung origin (uncertain origin)
Key Trial Info
Start Date :
January 6 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2039
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT06180005
Start Date
January 6 2024
End Date
December 30 2039
Last Update
August 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS
Aviano, Pordenone, Italy, 33081